This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Health Stocks in Motion

Shares of Favrille (FVRL) were among the best-performing health-related stocks Thursday, jumping 33% after the developer of cancer treatments said its FavId product received fast-track status from the Food and Drug Administration.

The treatment is used to combat B-cell follicular non-Hodgkin's lyphoma. FavId is currently being evaluated in a phase III clinical trial. "This decision by the FDA has the potential to save us valuable time in the regulatory approval process, and also serves as an important acknowledgement of the potential for FavId in the treatment of B-cell follicular NHL," the company said. Shares were trading up $1.33 to $5.37.

CryoLife (CRY) surged 20% after the biosurgical device company said the FDA approved its new 10-milliliter disposable syringe for BioGlue surgical adhesive. The BioGlue syringe is already available in the U.S. in 2-milliliter and 5-milliliter volumes. The 10-milliliter syringe, which is already being used in Europe, will be introduced into the U.S. market late in the first quarter, the company said. "The 10ml BioGlue Syringe provides surgeons with an effective adhesive in an easy-to-use, self-contained, disposable syringe, ideally suited for complex cardiovascular surgery procedures," CryoLife said in a statement. Shares were trading up 78 cents to $4.60.

Shares of Rockwell Medical Technologies (RMTI) rose 5% after the dialysis products maker received a $13 million purchase order for dialysis concentrate and supplies. The order is for dialysis business in Latin America. Rockwell said it anticipates fulfilling the entire order during 2006. "We anticipate that this order will have a favorable impact on both our sales and earnings during 2006," the company said. Shares were trading up 21 cents to $4.63.

Schiff Nutrition (WNI) fell 3% after the maker of nutritional supplements posted a big decline in second-quarter earnings and sales. The company, which was previously known as Weider Nutrition, earned $1.5 million, or 6 cents a share, on sales of $35.5 million. During the year-ago period the company earned $3.5 million, or 13 cents a share, on sales of $44.3 million. The sales decline, which was expected, was primarily due to the discontinuance of a private-label business, the company said. Shares were trading down 14 cents to $5.10.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,083.80 -2.83 -0.02%
S&P 500 1,987.98 +0.97 0.05%
NASDAQ 4,472.1080 -1.5890 -0.04%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs